JP2015504860A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504860A5 JP2015504860A5 JP2014546154A JP2014546154A JP2015504860A5 JP 2015504860 A5 JP2015504860 A5 JP 2015504860A5 JP 2014546154 A JP2014546154 A JP 2014546154A JP 2014546154 A JP2014546154 A JP 2014546154A JP 2015504860 A5 JP2015504860 A5 JP 2015504860A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- emulsion
- castor oil
- dry eye
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 17
- 235000019438 castor oil Nutrition 0.000 claims 6
- 239000004359 castor oil Substances 0.000 claims 6
- 239000000839 emulsion Substances 0.000 claims 6
- 206010013774 Dry eye Diseases 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000002335 preservative Effects 0.000 claims 4
- 239000003755 preservative agent Substances 0.000 claims 4
- 239000003995 emulsifying agent Substances 0.000 claims 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 1
- 229960000686 Benzalkonium Chloride Drugs 0.000 claims 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N Erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229940009714 Erythritol Drugs 0.000 claims 1
- 229950008882 Polysorbate Drugs 0.000 claims 1
- 229940068968 Polysorbate 80 Drugs 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- 239000000607 artificial tear Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- 229960001518 levocarnitine Drugs 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 239000004006 olive oil Substances 0.000 claims 1
- 235000008390 olive oil Nutrition 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
Claims (18)
- 人工涙液として有用な組成物であって、ヒマシ油を含む無塩エマルジョンであり、具体的にオリーブ油を除外し、かつポリソルベート、カルボキシメチルセルロース、およびグリセリンからなる群から選択される少なくとも1つの活性薬剤を含有する、組成物。
- 前記混合物は、0.1重量/重量%〜0.5重量/重量%のヒマシ油を含む、請求項1に記載の組成物。
- ヒマシ油は、前記エマルジョン中の唯一の油である、請求項2に記載の組成物。
- 前記ヒマシ油は、水相中に乳化されている、請求項3に記載の組成物。
- 前記ヒマシ油は、約0.25重量/重量%で存在する、請求項4に記載の組成物。
- 第1の乳化剤および第2の乳化剤を更に含む、請求項5に記載の組成物。
- 前記組成物は、防腐剤を含有する、請求項5に記載の組成物。
- 前記防腐剤は、PURITEおよび塩化ベンザルコニウム(benzalkoniuim chloride)からなる群から選択される、請求項7に記載の組成物。
- 前記防腐剤は、Purite(登録商標)であり、約0.01重量/体積%の濃度で存在する、請求項8に記載の組成物。
- ドライアイの治療における使用のためのエマルジョンであって、無塩であり、かつヒマシ油、ポリソルベート80、カルボキシメチルセルロース、およびグリセリンを含む、エマルジョン。
- 前記エマルジョンは、乳化剤ペムリン(pemulin)も含有する、請求項10に記載の組成物。
- エリトリトールおよびレボカルニチンを更に含む、請求項11に記載のエマルジョン。
- 表1に示すような、ドライアイを治療するためのエマルジョン。
- 表1に示すような組成物のいずれかを含む、ドライアイを治療するための医薬組成物。
- 前記表1に示すような組成物は、防腐剤を含まない、請求項14に記載の医薬組成物。
- 少なくとも1日1回適用されるように用いられる、請求項14に記載の医薬組成物。
- 前記表1に示すような組成物は、ドライアイ症候群の兆候を緩和する、請求項15に記載の医薬組成物。
- 前記表1に示すような組成物は、ドライアイ症候群を治療および予防する、請求項15に記載の医薬組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161568089P | 2011-12-07 | 2011-12-07 | |
US61/568,089 | 2011-12-07 | ||
US201261625401P | 2012-04-17 | 2012-04-17 | |
US61/625,401 | 2012-04-17 | ||
PCT/US2012/068615 WO2013086449A1 (en) | 2011-12-07 | 2012-12-07 | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015504860A JP2015504860A (ja) | 2015-02-16 |
JP2015504860A5 true JP2015504860A5 (ja) | 2016-02-04 |
JP6142419B2 JP6142419B2 (ja) | 2017-06-07 |
Family
ID=47459152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014546154A Active JP6142419B2 (ja) | 2011-12-07 | 2012-12-07 | 塩感受性エマルジョン系を用いたヒト涙液膜への効率的脂質送達 |
Country Status (28)
Country | Link |
---|---|
US (2) | US20130150324A1 (ja) |
EP (5) | EP4403220A3 (ja) |
JP (1) | JP6142419B2 (ja) |
KR (1) | KR102017922B1 (ja) |
CN (2) | CN104114152A (ja) |
AR (1) | AR089123A1 (ja) |
AU (2) | AU2012347459A1 (ja) |
BR (1) | BR112014013820A8 (ja) |
CA (1) | CA2858574C (ja) |
CL (1) | CL2014001518A1 (ja) |
CO (1) | CO6990739A2 (ja) |
DK (2) | DK2787969T3 (ja) |
ES (2) | ES2797650T3 (ja) |
HK (2) | HK1201458A1 (ja) |
HU (2) | HUE057140T2 (ja) |
IL (1) | IL233008A (ja) |
IN (1) | IN2014CN04809A (ja) |
MX (1) | MX355216B (ja) |
MY (1) | MY173378A (ja) |
PH (1) | PH12014501296A1 (ja) |
PL (2) | PL2787969T3 (ja) |
PT (2) | PT2787969T (ja) |
RU (1) | RU2014127074A (ja) |
SG (1) | SG11201403013VA (ja) |
SI (2) | SI2787968T1 (ja) |
TW (1) | TWI652072B (ja) |
WO (2) | WO2013086449A1 (ja) |
ZA (1) | ZA201404228B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
JOP20170147B1 (ar) | 2016-07-07 | 2021-08-17 | Salvat Lab Sa | تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة |
WO2018035469A1 (en) | 2016-08-19 | 2018-02-22 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
JP7311160B2 (ja) | 2017-08-18 | 2023-07-19 | アクリビスタ エルエルシー | ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物 |
CN112272578A (zh) | 2018-04-27 | 2021-01-26 | 阿勒根公司 | 抗微生物功效增强且毒性降低的亚氯酸钠组合物 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4201706A (en) | 1978-09-22 | 1980-05-06 | Burton, Parsons & Company, Inc. | Treatment of corneal edema |
ATE6466T1 (de) | 1979-10-26 | 1984-03-15 | Smith And Nephew Associated Companies P.L.C. | Autoklavierbare emulsionen. |
US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
IT1224795B (it) | 1988-12-01 | 1990-10-24 | Sigma Tau Ind Farmaceuti | Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento |
DE436726T1 (de) | 1989-08-03 | 1992-02-06 | Eisai Co., Ltd., Tokio/Tokyo | Verfahren zur photostabilisierung von augenspuelloesungen sowie photostabilisierte augenspuelloesung. |
US5681555A (en) | 1991-04-22 | 1997-10-28 | Gleich; Gerald J. | Method for the treatment of bronchial asthma by parenteral administration of anionic polymers |
DE4229494A1 (de) | 1992-09-04 | 1994-03-10 | Basotherm Gmbh | Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks |
CA2199610A1 (en) | 1994-09-14 | 1996-03-21 | Taisho Pharmaceutical Co., Ltd. | Eye drops for repairing repairing corneal damage |
US5980865A (en) | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
FI106923B (fi) | 1997-01-03 | 2001-05-15 | Cultor Ltd Finnsugar Bioproduc | Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa |
AR002194A1 (es) | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
IT1302307B1 (it) | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
DE69919379T2 (de) | 1998-11-13 | 2005-09-08 | Continental Projects Ltd. | Komplexe von hyaluronic saure/carnitinen und pharmazeutische und kosmetische zusammensetzungen |
JP2000159659A (ja) | 1998-11-30 | 2000-06-13 | Kazuo Tsubota | 眼科用人工涙液 |
US6228392B1 (en) | 1999-04-29 | 2001-05-08 | Gene Tools, Llc | Osmotic delivery composition, solution, and method |
DK2153819T3 (da) | 2000-07-14 | 2012-12-03 | Allergan Inc | Anvendelse af en opløselighedsforbedrende bestanddel i en vandig sammensætning omfattende brimonidintartrat |
AU781975B2 (en) | 2000-09-14 | 2005-06-23 | Hayashibara Co., Ltd | Pharmaceutical composition for ophthalmic use |
CA2428985C (en) | 2000-11-08 | 2011-05-24 | Bio-Concept Laboratories | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US7045121B2 (en) | 2001-12-14 | 2006-05-16 | Allergan, Inc. | Ophthalmic compositions for lubricating eyes and methods for making and using same |
JP2006504701A (ja) | 2002-09-30 | 2006-02-09 | マーク・エー・バビザイェフ | 眼疾患の局所的治療方法、並びに、その治療用組成物及び治療用手段 |
US7758883B2 (en) * | 2002-10-18 | 2010-07-20 | Aqueous Pharma Limited | Three layer artificial tear formulation |
US20040137079A1 (en) | 2003-01-08 | 2004-07-15 | Cook James N. | Contact lens and eye drop rewetter compositions and methods |
US6635654B1 (en) * | 2003-01-09 | 2003-10-21 | Allergan, Inc. | Ophthalmic compositions containing loratadine |
JPWO2004084877A1 (ja) | 2003-03-26 | 2006-06-29 | 株式会社メニコン | 眼科用組成物 |
KR101147046B1 (ko) * | 2003-06-13 | 2012-05-22 | 알콘, 인코퍼레이티드 | 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물 |
TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
US20050009836A1 (en) | 2003-06-26 | 2005-01-13 | Laskar Paul A. | Ophthalmic composition containing quinolones and method of use |
EP1683528A4 (en) * | 2003-11-10 | 2011-07-27 | Toray Industries | POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM |
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
US7288520B2 (en) * | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
US9561178B2 (en) * | 2006-07-25 | 2017-02-07 | Allergan, Inc. | Cyclosporin compositions |
WO2008035246A2 (en) * | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
CN101896160A (zh) * | 2006-10-17 | 2010-11-24 | 阿勒根公司 | 环胞菌素组合物 |
BRPI0808410A2 (pt) | 2007-02-28 | 2015-06-23 | Aciex Therapeutics Inc | Métodos e composições para normalizar secreções da glândula meibomiana |
JP4929245B2 (ja) | 2008-07-31 | 2012-05-09 | 株式会社ベッセル工業 | 工具類のグリップ |
WO2010141648A2 (en) * | 2009-06-05 | 2010-12-09 | Allergan, Inc. | Artificial tears and therapeutic uses |
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
-
2012
- 2012-12-07 IN IN4809CHN2014 patent/IN2014CN04809A/en unknown
- 2012-12-07 MX MX2014006804A patent/MX355216B/es active IP Right Grant
- 2012-12-07 SG SG11201403013VA patent/SG11201403013VA/en unknown
- 2012-12-07 BR BR112014013820A patent/BR112014013820A8/pt not_active Application Discontinuation
- 2012-12-07 JP JP2014546154A patent/JP6142419B2/ja active Active
- 2012-12-07 EP EP24167560.2A patent/EP4403220A3/en active Pending
- 2012-12-07 PL PL12808607T patent/PL2787969T3/pl unknown
- 2012-12-07 US US13/708,783 patent/US20130150324A1/en not_active Abandoned
- 2012-12-07 CN CN201280067685.0A patent/CN104114152A/zh active Pending
- 2012-12-07 WO PCT/US2012/068615 patent/WO2013086449A1/en active Application Filing
- 2012-12-07 AU AU2012347459A patent/AU2012347459A1/en not_active Abandoned
- 2012-12-07 PT PT128086071T patent/PT2787969T/pt unknown
- 2012-12-07 TW TW101146304A patent/TWI652072B/zh active
- 2012-12-07 MY MYPI2014001672A patent/MY173378A/en unknown
- 2012-12-07 DK DK12808607.1T patent/DK2787969T3/da active
- 2012-12-07 HU HUE12808607A patent/HUE057140T2/hu unknown
- 2012-12-07 PT PT128086063T patent/PT2787968T/pt unknown
- 2012-12-07 ES ES12808606T patent/ES2797650T3/es active Active
- 2012-12-07 KR KR1020147018598A patent/KR102017922B1/ko active IP Right Grant
- 2012-12-07 CA CA2858574A patent/CA2858574C/en active Active
- 2012-12-07 HU HUE12808606A patent/HUE049489T2/hu unknown
- 2012-12-07 DK DK12808606.3T patent/DK2787968T3/da active
- 2012-12-07 EP EP12808606.3A patent/EP2787968B1/en active Active
- 2012-12-07 AR ARP120104614A patent/AR089123A1/es not_active Application Discontinuation
- 2012-12-07 WO PCT/US2012/068603 patent/WO2013086438A1/en active Application Filing
- 2012-12-07 SI SI201231783T patent/SI2787968T1/sl unknown
- 2012-12-07 RU RU2014127074A patent/RU2014127074A/ru unknown
- 2012-12-07 EP EP12808607.1A patent/EP2787969B1/en active Active
- 2012-12-07 CN CN201810890387.0A patent/CN108969482A/zh active Pending
- 2012-12-07 ES ES12808607T patent/ES2896336T3/es active Active
- 2012-12-07 SI SI201231957T patent/SI2787969T1/sl unknown
- 2012-12-07 US US13/708,771 patent/US9314528B2/en active Active
- 2012-12-07 PL PL12808606T patent/PL2787968T3/pl unknown
- 2012-12-07 EP EP20153344.5A patent/EP3666257A1/en not_active Withdrawn
- 2012-12-07 EP EP21198843.1A patent/EP3981387A1/en active Pending
-
2014
- 2014-06-06 PH PH12014501296A patent/PH12014501296A1/en unknown
- 2014-06-08 IL IL233008A patent/IL233008A/en active IP Right Grant
- 2014-06-09 ZA ZA2014/04228A patent/ZA201404228B/en unknown
- 2014-06-09 CL CL2014001518A patent/CL2014001518A1/es unknown
- 2014-06-26 CO CO14138315A patent/CO6990739A2/es unknown
-
2015
- 2015-02-27 HK HK15102023.0A patent/HK1201458A1/xx unknown
- 2015-04-14 HK HK15103604.5A patent/HK1203057A1/xx unknown
-
2017
- 2017-11-27 AU AU2017265181A patent/AU2017265181B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015504860A5 (ja) | ||
MX2020012595A (es) | Composiciones farmaceuticas topicas. | |
SI2437762T1 (en) | Artificial tears and therapeutic use | |
PH12015502587B1 (en) | Ophthalmic nanoemulsion composition containing cyclosporine and method for preparing same | |
EP4374851A3 (en) | Ophthalmic composition for treatment of dry eye disease | |
BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
TR201904455T4 (tr) | Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları. | |
JP2018526325A5 (ja) | ||
EA201291108A1 (ru) | Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген | |
BR112014010275A2 (pt) | formulações para tratamento de diabetes | |
MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
BR112015001847A8 (pt) | Composições e tratamento para doenças e distúrbios nos olhos | |
NZ629045A (en) | Topical compositions comprising fipronil and permethrin and methods of use | |
RU2016135039A (ru) | Композиция для обработки поверхностных дефектов | |
EA201691490A1 (ru) | Фармацевтическая композиция, содержащая бринзоламид | |
RU2014127074A (ru) | Состав для эффективной доставки липидов в слезную пленку человека с использованием чувствительной к соли эмульсионной системы | |
RU2014148544A (ru) | Составы на основе полиинозиновой-полицитидиловой кислоты (poly(i:с)) для лечения инфекций верхних дыхательных путей | |
RU2019139886A (ru) | Терапевтическое средство против дисфункции мейбомиевых желез | |
JP2016502979A5 (ja) | ||
BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção | |
BR112017014016A2 (pt) | método de redução da pressão intraocular, e, composição farmacêutica. | |
GEP201706644B (en) | Insecticidal water-in-oil (w/o) formulation | |
FI3373976T3 (fi) | Topikaalisia formulaatioita ja niiden käyttöjä | |
EA201200754A1 (ru) | Традиционное китайское лекарственное средство, содержащее экстракты дан-шен (danshen) и сан-ки (sanqi), и его применение | |
JP2016175884A5 (ja) |